CT:TLRY Tilray, Inc. - Class 2

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. was incorporated in 2018 and is headquartered in Nanaimo, Canada.

This company cross-lists their shares on a U.S. stock exchange. See the related U.S. symbol TLRY.

11.68 CAD
As of 12/06/2021


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Developed markets ex-US
GICS sector:  Health Care
Industry:  Drug Manufacturers-Specialty &
Index country:  Canada
Country of incorporation:  USA
IPO date:  01/01/1900
Stock exchange:    Toronto Stock Exchange
Exchange country:   Canada
Market cap:   5,317,169,508 CAD
Current dividend yield:   0.00%
CUSIP:    
ISIN:        US88688T1007
Sedol:      

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy